| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLCO1B7 SLC6A2 TIMM17B SLC22A9 SLC22A25 SLC38A10 CNNM2 SLC4A7 SLC18A2 SV2B SV2A SLC22A11 SLC6A20 SLC22A15 APOF SLC5A7 SLC4A10 SLC16A11 CLDN4 SLC1A7 SLC2A3 ABCB1 ABCB4 | 2.71e-12 | 1289 | 63 | 23 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLCO1B7 SLC6A2 TIMM17B SLC22A9 SLC22A25 SLC38A10 CNNM2 SLC4A7 SLC18A2 SV2B SV2A SLC22A11 SLC6A20 SLC22A15 SLC5A7 SLC4A10 SLC16A11 CLDN4 SLC1A7 SLC2A3 ABCB1 ABCB4 | 3.98e-12 | 1180 | 63 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLCO1B7 SLC22A9 SLC22A25 SLC38A10 SLC4A7 SLC22A11 SLC6A20 SLC4A10 SLC16A11 SLC1A7 SLC2A3 ABCB1 | 1.09e-10 | 293 | 63 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLCO1B7 SLC6A2 SLC22A9 SLC22A25 SLC4A7 SLC18A2 SLC22A11 SLC6A20 SLC5A7 SLC4A10 SLC16A11 SLC1A7 | 1.23e-10 | 296 | 63 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLCO1B7 SLC6A2 SLC22A9 SLC22A25 SLC4A7 SLC18A2 SLC22A11 SLC6A20 SLC5A7 SLC4A10 SLC16A11 SLC1A7 ABCB1 ABCB4 | 2.09e-10 | 477 | 63 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 6.39e-09 | 81 | 63 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | symporter activity | SLC6A2 SLC4A7 SLC18A2 SLC6A20 SLC5A7 SLC4A10 SLC16A11 SLC1A7 | 2.30e-08 | 150 | 63 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 9.38e-08 | 119 | 63 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 2.66e-07 | 18 | 63 | 4 | GO:0015347 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLCO1B7 SLC22A9 SLC22A25 SLC38A10 SLC6A20 SLC16A11 SLC1A7 ABCB1 | 2.77e-07 | 207 | 63 | 8 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLCO1B7 SLC22A9 SLC22A25 SLC38A10 SLC6A20 SLC16A11 SLC1A7 ABCB1 | 2.87e-07 | 208 | 63 | 8 | GO:0005342 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.10e-06 | 171 | 63 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.10e-06 | 171 | 63 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.74e-06 | 196 | 63 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 8.06e-06 | 151 | 63 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 2.93e-05 | 3 | 63 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | hedgehog receptor activity | 2.93e-05 | 3 | 63 | 2 | GO:0008158 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 4.43e-05 | 301 | 63 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.66e-05 | 125 | 63 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 5.85e-05 | 4 | 63 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | smoothened binding | 5.85e-05 | 4 | 63 | 2 | GO:0005119 | |
| GeneOntologyMolecularFunction | hedgehog family protein binding | 5.85e-05 | 4 | 63 | 2 | GO:0097108 | |
| GeneOntologyMolecularFunction | amino-acid betaine transmembrane transporter activity | 5.85e-05 | 4 | 63 | 2 | GO:0015199 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 8.32e-05 | 73 | 63 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | short-chain fatty acid transmembrane transporter activity | 9.74e-05 | 5 | 63 | 2 | GO:0015636 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.03e-04 | 465 | 63 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A2 CNNM2 SLC4A7 SLC18A2 SLC22A11 SLC6A20 SLC5A7 SLC4A10 CLDN4 SLC1A7 | 1.21e-04 | 758 | 63 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.37e-04 | 83 | 63 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.39e-04 | 32 | 63 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 1.46e-04 | 6 | 63 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.88e-04 | 90 | 63 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 2.71e-04 | 8 | 63 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 4.30e-04 | 201 | 63 | 5 | GO:0061135 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 6.34e-04 | 12 | 63 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 6.34e-04 | 12 | 63 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 7.47e-04 | 13 | 63 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 7.64e-04 | 627 | 63 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A2 CNNM2 SLC4A7 SLC18A2 SLC6A20 SLC5A7 SLC4A10 CLDN4 SLC1A7 | 8.12e-04 | 793 | 63 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 8.70e-04 | 14 | 63 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | antiporter activity | 9.49e-04 | 138 | 63 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 1.00e-03 | 15 | 63 | 2 | GO:0015651 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 1.00e-03 | 15 | 63 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.11e-03 | 664 | 63 | 8 | GO:0008324 | |
| GeneOntologyMolecularFunction | K63-linked deubiquitinase activity | 1.14e-03 | 16 | 63 | 2 | GO:0061578 | |
| GeneOntologyMolecularFunction | floppase activity | 1.14e-03 | 16 | 63 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.29e-03 | 17 | 63 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 1.30e-03 | 257 | 63 | 5 | GO:0061134 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.41e-03 | 70 | 63 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.47e-03 | 71 | 63 | 3 | GO:0015179 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.62e-03 | 19 | 63 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.79e-03 | 20 | 63 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | proteasome binding | 1.79e-03 | 20 | 63 | 2 | GO:0070628 | |
| GeneOntologyMolecularFunction | folic acid binding | 1.79e-03 | 20 | 63 | 2 | GO:0005542 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.79e-03 | 20 | 63 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | fatty acid transmembrane transporter activity | 2.37e-03 | 23 | 63 | 2 | GO:0015245 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.37e-03 | 23 | 63 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 2.37e-03 | 23 | 63 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 2.51e-03 | 180 | 63 | 4 | GO:0004866 | |
| GeneOntologyMolecularFunction | amide binding | 2.52e-03 | 299 | 63 | 5 | GO:0033218 | |
| GeneOntologyMolecularFunction | protein kinase activity | 2.75e-03 | 600 | 63 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.88e-03 | 187 | 63 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.03e-03 | 26 | 63 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.51e-03 | 28 | 63 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 3.77e-03 | 29 | 63 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 4.46e-03 | 105 | 63 | 3 | GO:0004867 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.46e-03 | 105 | 63 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 4.57e-03 | 32 | 63 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 4.86e-03 | 33 | 63 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 5.15e-03 | 34 | 63 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 5.45e-03 | 35 | 63 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 5.73e-03 | 363 | 63 | 5 | GO:0106310 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 6.81e-03 | 709 | 63 | 7 | GO:0016773 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 7.42e-03 | 41 | 63 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 7.56e-03 | 127 | 63 | 3 | GO:0016616 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLCO1B7 SLC22A9 EPRS1 SLC22A25 SLC38A10 SLC4A7 SV2A SLC22A11 SLC6A20 SLC4A10 SLC16A11 SLC1A7 SLC2A3 ABCB1 ABCB4 | 3.03e-11 | 515 | 63 | 15 | GO:0015711 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLCO1B7 SLC22A9 EPRS1 SLC38A10 SV2A SLC22A11 SLC6A20 SLC16A11 SLC1A7 ABCB1 ABCB4 | 4.08e-08 | 410 | 63 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLCO1B7 SLC22A9 EPRS1 SLC38A10 SV2A SLC22A11 SLC6A20 SLC16A11 SLC1A7 ABCB1 ABCB4 | 4.29e-08 | 412 | 63 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLCO1B7 SLC6A2 SLC22A9 AKT3 SLC22A25 CNNM2 SLC4A7 PIRT SLC18A2 SLC22A11 SLC6A20 SLC22A15 SLC5A7 SLC4A10 CLDN4 SLC1A7 ABCB1 | 4.88e-07 | 1374 | 63 | 17 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.26e-06 | 180 | 63 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | SLC6A2 USP14 PTPRN2 SLC18A2 SV2B SV2A ENPP1 GLS SLC5A7 SLC4A10 PRKCZ SLC1A7 EPHA4 | 3.81e-06 | 931 | 63 | 13 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | SLC6A2 USP14 PTPRN2 SLC18A2 SV2B SV2A ENPP1 GLS SLC5A7 SLC4A10 PRKCZ SLC1A7 EPHA4 | 3.81e-06 | 931 | 63 | 13 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | SLC6A2 USP14 PTPRN2 SLC18A2 SV2B SV2A ENPP1 GLS SLC5A7 SLC4A10 PRKCZ SLC1A7 EPHA4 | 4.19e-06 | 939 | 63 | 13 | GO:0099537 |
| GeneOntologyBiologicalProcess | synaptic signaling | SLC6A2 USP14 PTPRN2 SLC18A2 SV2B SV2A ENPP1 GLS SLC5A7 SLC4A10 PRKCZ SLC1A7 EPHA4 | 6.37e-06 | 976 | 63 | 13 | GO:0099536 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.04e-05 | 163 | 63 | 6 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.19e-05 | 167 | 63 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.38e-05 | 259 | 63 | 7 | GO:0006836 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 2.75e-05 | 3 | 63 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | amino acid transport | 2.87e-05 | 195 | 63 | 6 | GO:0006865 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 4.70e-05 | 213 | 63 | 6 | GO:0015718 | |
| GeneOntologyBiologicalProcess | lipid localization | 5.16e-05 | 565 | 63 | 9 | GO:0010876 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 9.13e-05 | 5 | 63 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.05e-04 | 153 | 63 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | regeneration | 1.19e-04 | 252 | 63 | 6 | GO:0031099 | |
| GeneOntologyBiologicalProcess | epidermal cell fate specification | 1.37e-04 | 6 | 63 | 2 | GO:0009957 | |
| GeneOntologyBiologicalProcess | lipid transport | 1.47e-04 | 506 | 63 | 8 | GO:0006869 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.91e-04 | 275 | 63 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.41e-04 | 183 | 63 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | paranodal junction assembly | 2.54e-04 | 8 | 63 | 2 | GO:0030913 | |
| GeneOntologyBiologicalProcess | negative regulation of smoothened signaling pathway | 2.86e-04 | 42 | 63 | 3 | GO:0045879 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CNNM2 SLC4A7 PTPRN2 SV2B SV2A ENPP1 GLS SLC4A10 PTCH1 NR1D1 TMEM64 ABCB4 | 3.46e-04 | 1249 | 63 | 12 | GO:0048878 |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 5.39e-04 | 52 | 63 | 3 | GO:0001504 | |
| GeneOntologyBiologicalProcess | chloride transport | 6.35e-04 | 128 | 63 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 6.59e-04 | 228 | 63 | 5 | GO:0046777 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLCO1B7 SLC22A9 SLC22A25 CNNM2 SLC4A7 ENPP1 SLC22A11 SLC4A10 CLDN4 | 1.09e-06 | 354 | 63 | 9 | GO:0009925 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 1.11e-06 | 179 | 63 | 7 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 1.11e-06 | 179 | 63 | 7 | GO:0030672 | |
| GeneOntologyCellularComponent | apical part of cell | SLC4A7 CD9 SLC22A11 SLC6A20 SLC5A7 SLC4A10 CLDN4 PRKCZ PTCH1 ABCB1 ABCB4 | 1.39e-06 | 592 | 63 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC4A7 CD9 SLC22A11 SLC6A20 SLC5A7 SLC4A10 CLDN4 PRKCZ ABCB1 ABCB4 | 1.82e-06 | 487 | 63 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | basal part of cell | SLCO1B7 SLC22A9 SLC22A25 CNNM2 SLC4A7 ENPP1 SLC22A11 SLC4A10 CLDN4 | 1.88e-06 | 378 | 63 | 9 | GO:0045178 |
| GeneOntologyCellularComponent | presynapse | SLC6A2 USP14 PTPRN2 SLC18A2 SV2B SV2A SLC5A7 SLC4A10 ATM SLC1A7 SLC2A3 EPHA4 | 1.13e-05 | 886 | 63 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | transport vesicle membrane | 2.80e-05 | 293 | 63 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | synaptic vesicle | 3.25e-05 | 300 | 63 | 7 | GO:0008021 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.90e-05 | 320 | 63 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | exocytic vesicle | 4.90e-05 | 320 | 63 | 7 | GO:0070382 | |
| GeneOntologyCellularComponent | neuronal cell body | SLC6A2 SLC18A2 SV2A ENPP1 SLC5A7 SLC4A10 PRKCZ NR1D1 SLC2A3 EPHA4 | 1.84e-04 | 835 | 63 | 10 | GO:0043025 |
| GeneOntologyCellularComponent | intercellular canaliculus | 3.17e-04 | 9 | 63 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | basal dendrite | 3.96e-04 | 10 | 63 | 2 | GO:0097441 | |
| GeneOntologyCellularComponent | axon terminus | 4.27e-04 | 210 | 63 | 5 | GO:0043679 | |
| GeneOntologyCellularComponent | cell body | SLC6A2 SLC18A2 SV2A ENPP1 SLC5A7 SLC4A10 PRKCZ NR1D1 SLC2A3 EPHA4 | 4.30e-04 | 929 | 63 | 10 | GO:0044297 |
| GeneOntologyCellularComponent | neuron projection terminus | 6.85e-04 | 233 | 63 | 5 | GO:0044306 | |
| GeneOntologyCellularComponent | membrane raft | 7.66e-04 | 362 | 63 | 6 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 7.88e-04 | 364 | 63 | 6 | GO:0098857 | |
| GeneOntologyCellularComponent | transport vesicle | 9.29e-04 | 519 | 63 | 7 | GO:0030133 | |
| GeneOntologyCellularComponent | somatodendritic compartment | SLC6A2 SLC18A2 SV2A ENPP1 SLC5A7 SLC4A10 PRKCZ PTCH1 NR1D1 SLC2A3 EPHA4 | 1.01e-03 | 1228 | 63 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | plasma membrane raft | 1.01e-03 | 147 | 63 | 4 | GO:0044853 | |
| GeneOntologyCellularComponent | axon | SLC6A2 PTPRN2 SLC18A2 SLC5A7 SLC4A10 PRKCZ PTCH1 SLC1A7 EPHA4 | 1.34e-03 | 891 | 63 | 9 | GO:0030424 |
| GeneOntologyCellularComponent | cell-cell junction | 1.96e-03 | 591 | 63 | 7 | GO:0005911 | |
| GeneOntologyCellularComponent | distal axon | 1.96e-03 | 435 | 63 | 6 | GO:0150034 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 2.35e-03 | 185 | 63 | 4 | GO:0101002 | |
| GeneOntologyCellularComponent | anchoring junction | 2.49e-03 | 976 | 63 | 9 | GO:0070161 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 3.04e-03 | 817 | 63 | 8 | GO:0098978 | |
| GeneOntologyCellularComponent | terminal bouton | 3.05e-03 | 96 | 63 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | secretory vesicle | IMPDH1 CD9 PTPRN2 SLC18A2 SV2B SV2A SLC5A7 ATM PSMD14 SLC2A3 | 3.88e-03 | 1246 | 63 | 10 | GO:0099503 |
| GeneOntologyCellularComponent | dendrite | 4.10e-03 | 858 | 63 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 4.15e-03 | 860 | 63 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | apical dendrite | 4.18e-03 | 32 | 63 | 2 | GO:0097440 | |
| GeneOntologyCellularComponent | perikaryon | 4.59e-03 | 223 | 63 | 4 | GO:0043204 | |
| GeneOntologyCellularComponent | neuromuscular junction | 4.71e-03 | 112 | 63 | 3 | GO:0031594 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 5.43e-03 | 1307 | 63 | 10 | GO:0030659 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 5.69e-03 | 237 | 63 | 4 | GO:0030136 | |
| GeneOntologyCellularComponent | vesicle membrane | 5.97e-03 | 1325 | 63 | 10 | GO:0012506 | |
| HumanPheno | Odontogenic keratocysts of the jaw | 8.71e-05 | 3 | 28 | 2 | HP:0010603 | |
| HumanPheno | Cardiac fibroma | 8.71e-05 | 3 | 28 | 2 | HP:0010617 | |
| HumanPheno | Ovarian fibroma | 8.71e-05 | 3 | 28 | 2 | HP:0010618 | |
| HumanPheno | Bridged sella turcica | 8.71e-05 | 3 | 28 | 2 | HP:0005449 | |
| HumanPheno | Bifid ribs | 9.61e-05 | 17 | 28 | 3 | HP:0000892 | |
| Domain | MFS | SLCO1B7 SLC22A9 SLC22A25 SLC18A2 SV2B SV2A SLC22A11 SLC22A15 SLC16A11 SLC2A3 | 2.70e-12 | 108 | 63 | 10 | PS50850 |
| Domain | MFS_dom | SLCO1B7 SLC22A9 SLC22A25 SLC18A2 SV2B SV2A SLC22A11 SLC22A15 SLC16A11 SLC2A3 | 2.38e-11 | 134 | 63 | 10 | IPR020846 |
| Domain | MFS_1 | 7.04e-09 | 77 | 63 | 7 | PF07690 | |
| Domain | MFS | 7.04e-09 | 77 | 63 | 7 | IPR011701 | |
| Domain | MFS_sugar_transport-like | 1.29e-07 | 36 | 63 | 5 | IPR005828 | |
| Domain | Sugar_tr | 1.29e-07 | 36 | 63 | 5 | PF00083 | |
| Domain | TM_rcpt_patched | 1.12e-05 | 2 | 63 | 2 | IPR004766 | |
| Domain | SV2 | 3.35e-05 | 3 | 63 | 2 | IPR022308 | |
| Domain | Pentapeptide_4 | 3.35e-05 | 3 | 63 | 2 | PF13599 | |
| Domain | 5peptide_repeat | 6.69e-05 | 4 | 63 | 2 | IPR001646 | |
| Domain | Anion_exchange | 1.11e-04 | 5 | 63 | 2 | IPR001717 | |
| Domain | Sugar_transporter_CS | 1.69e-04 | 32 | 63 | 3 | IPR005829 | |
| Domain | ANION_EXCHANGER_2 | 2.33e-04 | 7 | 63 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 2.33e-04 | 7 | 63 | 2 | PS00219 | |
| Domain | Pkinase_C | 2.62e-04 | 37 | 63 | 3 | IPR017892 | |
| Domain | Pkinase_C | 3.82e-04 | 42 | 63 | 3 | PF00433 | |
| Domain | Band3_cytoplasmic_dom | 3.97e-04 | 9 | 63 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 3.97e-04 | 9 | 63 | 2 | PF07565 | |
| Domain | - | 3.97e-04 | 9 | 63 | 2 | 3.40.1100.10 | |
| Domain | Ptc/Disp | 3.97e-04 | 9 | 63 | 2 | IPR003392 | |
| Domain | Patched | 3.97e-04 | 9 | 63 | 2 | PF02460 | |
| Domain | HCO3_cotransp | 4.95e-04 | 10 | 63 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 4.95e-04 | 10 | 63 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 4.95e-04 | 10 | 63 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 4.95e-04 | 10 | 63 | 2 | IPR003020 | |
| Domain | SSD | 8.53e-04 | 13 | 63 | 2 | IPR000731 | |
| Domain | SSD | 8.53e-04 | 13 | 63 | 2 | PS50156 | |
| Domain | AGC-kinase_C | 8.93e-04 | 56 | 63 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 8.93e-04 | 56 | 63 | 3 | PS51285 | |
| Domain | S_TK_X | 8.93e-04 | 56 | 63 | 3 | SM00133 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.65e-03 | 18 | 63 | 2 | PS00754 | |
| Domain | SNF | 1.85e-03 | 19 | 63 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.85e-03 | 19 | 63 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.85e-03 | 19 | 63 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 1.85e-03 | 19 | 63 | 2 | IPR000175 | |
| Domain | CBS_dom | 2.05e-03 | 20 | 63 | 2 | IPR000644 | |
| Domain | CBS | 2.05e-03 | 20 | 63 | 2 | PF00571 | |
| Domain | CBS | 2.05e-03 | 20 | 63 | 2 | PS51371 | |
| Domain | Tetraspanin_CS | 2.26e-03 | 21 | 63 | 2 | IPR018503 | |
| Domain | Kinase-like_dom | 2.26e-03 | 542 | 63 | 7 | IPR011009 | |
| Domain | ABC_membrane | 2.95e-03 | 24 | 63 | 2 | PF00664 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLCO1B7 SLC6A2 SLC4A7 SLC18A2 SLC6A20 SLC22A15 SLC5A7 SLC4A10 SLC1A7 SLC2A3 | 8.85e-09 | 238 | 50 | 10 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A2 SLC4A7 SLC18A2 SLC22A11 SLC6A20 SLC22A15 SLC5A7 SLC4A10 SLC1A7 SLC2A3 | 1.36e-08 | 249 | 50 | 10 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A2 SLC4A7 SLC18A2 SLC22A11 SLC6A20 SLC22A15 APOF SLC5A7 SLC4A10 PSMD14 SLC1A7 SLC2A3 ABCB1 ABCB4 | 1.60e-07 | 736 | 50 | 14 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLCO1B7 SLC6A2 SLC4A7 SLC18A2 SLC6A20 SLC22A15 SLC5A7 SLC4A10 PSMD14 SLC1A7 SLC2A3 ABCB1 ABCB4 | 4.71e-07 | 681 | 50 | 13 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 4.81e-07 | 84 | 50 | 6 | M27334 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 6.99e-06 | 76 | 50 | 5 | MM15072 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 3.09e-05 | 51 | 50 | 4 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 3.09e-05 | 51 | 50 | 4 | MM14499 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 3.91e-05 | 19 | 50 | 3 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 3.91e-05 | 19 | 50 | 3 | MM15107 | |
| Pathway | REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD | 1.22e-04 | 5 | 50 | 2 | M27427 | |
| Pathway | REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS | 1.44e-04 | 29 | 50 | 3 | M27431 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 1.83e-04 | 6 | 50 | 2 | M22078 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 2.56e-04 | 7 | 50 | 2 | M27501 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 2.76e-04 | 36 | 50 | 3 | MM15603 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 2.98e-04 | 91 | 50 | 4 | M39570 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 3.00e-04 | 37 | 50 | 3 | M41813 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 3.96e-04 | 177 | 50 | 5 | M27476 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 3.96e-04 | 98 | 50 | 4 | MM15942 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR | 4.37e-04 | 9 | 50 | 2 | M47893 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 5.45e-04 | 10 | 50 | 2 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 5.45e-04 | 10 | 50 | 2 | MM15073 | |
| Pathway | REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS | 5.45e-04 | 10 | 50 | 2 | M27018 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.72e-04 | 108 | 50 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.92e-04 | 109 | 50 | 4 | MM15074 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 8.11e-04 | 314 | 50 | 6 | M39428 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 1.07e-03 | 57 | 50 | 3 | M39812 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 1.09e-03 | 14 | 50 | 2 | M47414 | |
| Pathway | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | 1.26e-03 | 15 | 50 | 2 | M888 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.26e-03 | 15 | 50 | 2 | MM15697 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 10488067 | ||
| Pubmed | SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis. | 3.23e-06 | 2 | 63 | 2 | 19176798 | |
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 3.23e-06 | 2 | 63 | 2 | 21705081 | |
| Pubmed | Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer. | 3.23e-06 | 2 | 63 | 2 | 20501645 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 10552998 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 28441502 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 3.23e-06 | 2 | 63 | 2 | 9196326 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22184139 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 18524768 | ||
| Pubmed | Isolation and expression of a complementary DNA that confers multidrug resistance. | 3.23e-06 | 2 | 63 | 2 | 3022150 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 2570420 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 8898203 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 30166346 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 2473069 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 28274756 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 19185004 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15142440 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 18215618 | ||
| Pubmed | Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. | 3.23e-06 | 2 | 63 | 2 | 18815274 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 7681585 | ||
| Pubmed | What have we learnt thus far from mice with disrupted P-glycoprotein genes? | 3.23e-06 | 2 | 63 | 2 | 8763339 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 29230040 | ||
| Pubmed | Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. | 3.23e-06 | 2 | 63 | 2 | 9473291 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 2471060 | ||
| Pubmed | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 3.23e-06 | 2 | 63 | 2 | 18231753 | |
| Pubmed | SV2 mediates entry of tetanus neurotoxin into central neurons. | 3.23e-06 | 2 | 63 | 2 | 21124874 | |
| Pubmed | Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression. | 3.23e-06 | 2 | 63 | 2 | 26834157 | |
| Pubmed | ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. | 3.23e-06 | 2 | 63 | 2 | 32058310 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 3768958 | ||
| Pubmed | Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. | 3.23e-06 | 2 | 63 | 2 | 38522903 | |
| Pubmed | Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. | 3.23e-06 | 2 | 63 | 2 | 3477522 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 34990798 | ||
| Pubmed | SV2 regulates neurotransmitter release via multiple mechanisms. | 3.23e-06 | 2 | 63 | 2 | 20702688 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 16857572 | ||
| Pubmed | Synaptic vesicle protein 2 enhances release probability at quiescent synapses. | 3.23e-06 | 2 | 63 | 2 | 16436618 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 17928512 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 1969609 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24140176 | ||
| Pubmed | Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. | 3.23e-06 | 2 | 63 | 2 | 9419367 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 19221557 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 2248681 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22847229 | ||
| Pubmed | Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). | 3.23e-06 | 2 | 63 | 2 | 10611374 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 17440929 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 7832992 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 11826402 | ||
| Pubmed | SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. | 3.23e-06 | 2 | 63 | 2 | 10624962 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 10453001 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 10660625 | ||
| Pubmed | 4.53e-06 | 18 | 63 | 3 | 33514739 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 6.92e-06 | 736 | 63 | 9 | 29676528 | |
| Pubmed | 8.70e-06 | 405 | 63 | 7 | 38187761 | ||
| Pubmed | Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. | 9.68e-06 | 3 | 63 | 2 | 7814632 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 25085974 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 17079864 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 9778357 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 23617838 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 16189177 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 20865662 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 8547326 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 18501590 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 23937191 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 26015569 | ||
| Pubmed | Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns. | 9.68e-06 | 3 | 63 | 2 | 33588752 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 9305920 | ||
| Pubmed | Ptch2, a second mouse Patched gene is co-expressed with Sonic hedgehog. | 9.68e-06 | 3 | 63 | 2 | 9462734 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 31317476 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 25029804 | ||
| Pubmed | Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter. | 9.68e-06 | 3 | 63 | 2 | 16150593 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 24732756 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 9542318 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 20332632 | ||
| Pubmed | No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. | 9.68e-06 | 3 | 63 | 2 | 18977120 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 16543415 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 12687700 | ||
| Pubmed | SV2 modulates the size of the readily releasable pool of secretory vesicles. | 9.68e-06 | 3 | 63 | 2 | 11483953 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 31145830 | ||
| Pubmed | Structural and functional characterization of the mouse multidrug resistance gene family. | 9.68e-06 | 3 | 63 | 2 | 1980424 | |
| Pubmed | Mechanism of inhibition of the tumor suppressor Patched by Sonic Hedgehog. | 9.68e-06 | 3 | 63 | 2 | 27647915 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 15037815 | ||
| Pubmed | Loss of the SV2-like protein SVOP produces no apparent deficits in laboratory mice. | 1.93e-05 | 4 | 63 | 2 | 23894296 | |
| Pubmed | Fibroblast growth factor 10 is required for proper development of the mouse whiskers. | 1.93e-05 | 4 | 63 | 2 | 12615071 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 14592810 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 11668586 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 19417012 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 18466105 | ||
| Pubmed | Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. | 1.93e-05 | 4 | 63 | 2 | 14980210 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 15068970 | ||
| Pubmed | Overlapping and non-overlapping Ptch2 expression with Shh during mouse embryogenesis. | 1.93e-05 | 4 | 63 | 2 | 9858693 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 33047712 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 20410110 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 19962312 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 2069718 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 18162577 | ||
| Pubmed | Synaptotagmin 1-triggered lipid signaling facilitates coupling of exo- and endocytosis. | 1.93e-05 | 4 | 63 | 2 | 37738980 | |
| Pubmed | Isolation of a family of organic anion transporters from human liver and kidney. | 1.93e-05 | 4 | 63 | 2 | 11327718 | |
| Pubmed | 2.46e-05 | 31 | 63 | 3 | 15217342 | ||
| Pubmed | 2.71e-05 | 32 | 63 | 3 | 14973295 | ||
| Pubmed | Patched1 and Patched2 inhibit Smoothened non-cell autonomously. | 3.22e-05 | 5 | 63 | 2 | 27552050 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 9512493 | ||
| Cytoband | 12p13.3 | 9.74e-06 | 30 | 63 | 3 | 12p13.3 | |
| Cytoband | 2q12 | 1.21e-04 | 12 | 63 | 2 | 2q12 | |
| Cytoband | 2q24.2 | 4.21e-04 | 22 | 63 | 2 | 2q24.2 | |
| Cytoband | 11q12.3 | 1.26e-03 | 38 | 63 | 2 | 11q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 1.43e-03 | 353 | 63 | 4 | chr12p13 | |
| Cytoband | 11q13.1 | 3.43e-03 | 63 | 63 | 2 | 11q13.1 | |
| GeneFamily | Solute carriers | SLCO1B7 SLC6A2 SLC22A9 SLC22A25 SLC38A10 SLC4A7 SLC18A2 SLC22A11 SLC6A20 SLC22A15 SLC5A7 SLC4A10 SLC16A11 SLC1A7 SLC2A3 | 9.27e-16 | 395 | 38 | 15 | 752 |
| GeneFamily | ATP binding cassette subfamily B | 2.34e-04 | 11 | 38 | 2 | 806 | |
| GeneFamily | CD molecules|Tetraspanins | 2.18e-03 | 33 | 38 | 2 | 768 | |
| GeneFamily | Olfactory receptors, family 52 | 4.75e-03 | 49 | 38 | 2 | 165 | |
| Coexpression | RATTENBACHER_BOUND_BY_CELF1 | 9.71e-07 | 444 | 62 | 9 | M2505 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | EPRS1 AKT3 SLC4A7 DPH5 NCAPD2 SLC4A10 ATM PTCH1 NR1D1 ZAP70 EPHA4 ABCB1 | 3.74e-06 | 1012 | 62 | 12 | M40864 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | PLAAT3 EPRS1 AKT3 SLC4A7 SLC18A2 GLS MTR ATM PSMD14 ABCB1 GNPAT ABCB4 | 2.35e-05 | 1215 | 62 | 12 | M41122 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL | 2.90e-05 | 375 | 62 | 7 | M45799 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP | 5.18e-05 | 411 | 62 | 7 | M19971 | |
| Coexpression | GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP | 6.46e-05 | 178 | 62 | 5 | M5639 | |
| Coexpression | KORKOLA_CHORIOCARCINOMA_UP | 8.21e-05 | 6 | 62 | 2 | M14050 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 1.02e-04 | 196 | 62 | 5 | M8683 | |
| Coexpression | GSE10325_BCELL_VS_MYELOID_UP | 1.04e-04 | 197 | 62 | 5 | M3081 | |
| Coexpression | GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN | 1.09e-04 | 199 | 62 | 5 | M5065 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP | 1.09e-04 | 199 | 62 | 5 | M5694 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | 1.12e-04 | 200 | 62 | 5 | M9411 | |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN | 1.12e-04 | 200 | 62 | 5 | M6430 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP | 1.12e-04 | 200 | 62 | 5 | M7159 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN | 1.12e-04 | 200 | 62 | 5 | M7205 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_4H_BMDC_DN | 1.12e-04 | 200 | 62 | 5 | M3942 | |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_DN | 1.12e-04 | 200 | 62 | 5 | M5674 | |
| Coexpression | KORKOLA_SEMINOMA_UP | 1.56e-04 | 44 | 62 | 3 | M18387 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_CAJAL_RETZIUS | 1.73e-04 | 499 | 62 | 7 | M39017 | |
| Coexpression | DESCARTES_FETAL_LIVER_HEPATOBLASTS | 1.86e-04 | 505 | 62 | 7 | M40234 | |
| Coexpression | MATSUDA_NATURAL_KILLER_DIFFERENTIATION | 2.23e-04 | 520 | 62 | 7 | MM1008 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Sp, TCRb aGalCer-loaded CD1d-tetramer CD4, Spleen, avg-2 | 5.14e-05 | 333 | 62 | 7 | GSM538323_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | 8.53e-05 | 361 | 62 | 7 | GSM538385_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 9.78e-05 | 369 | 62 | 7 | GSM605891_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000 | SLC6A2 PLAAT3 AKT3 SLC18A2 APOF MTR SERPINA10 FTCD SLC2A3 ABCB4 | 1.04e-04 | 805 | 62 | 10 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 1.06e-04 | 374 | 62 | 7 | GSM538389_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.17e-04 | 380 | 62 | 7 | GSM605901_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th.TCRbko, TCRd+ Vg2- CD24+, Thymus, avg-3 | 1.51e-04 | 396 | 62 | 7 | GSM605799_500 | |
| CoexpressionAtlas | NK cells, NK.49H+.Sp, NK1.1+ Ly49H+, Spleen, avg-3 | 1.69e-04 | 403 | 62 | 7 | GSM605814_500 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 1.74e-07 | 174 | 63 | 6 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILC3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.65e-07 | 187 | 63 | 6 | a037631a01d2cce088e6522dceeb1eee806522a1 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.03e-06 | 168 | 63 | 5 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.40e-06 | 171 | 63 | 5 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | Mild-Lymphoid-T-innate_T|Mild / Condition, Lineage, Cell class and cell subclass | 5.50e-06 | 179 | 63 | 5 | abc0fbe101a464a2c85755a974a3d5c2b968fe46 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.80e-06 | 181 | 63 | 5 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.28e-06 | 184 | 63 | 5 | 571136c832cb8c08457744152231537aa8e8abd7 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 6.28e-06 | 184 | 63 | 5 | d97471a4fe17cba6880ccf1a04cc00c741558124 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILC3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.62e-06 | 186 | 63 | 5 | ac1d2a94674bd15885e70502abad3a2ff3c21d73 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.34e-06 | 190 | 63 | 5 | 326002d7f9de5e425cee76d9a0277f42d79058e2 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.53e-06 | 191 | 63 | 5 | 3a5081dc542ac6262acfe5f8084a86616fee8082 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.53e-06 | 191 | 63 | 5 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | wk_08-11-Epithelial-PNS-SST+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.53e-06 | 191 | 63 | 5 | df2bef74a54f4c23c99bd3b93225fd36bcd90723 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.53e-06 | 191 | 63 | 5 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.53e-06 | 191 | 63 | 5 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 7.53e-06 | 191 | 63 | 5 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.53e-06 | 191 | 63 | 5 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius-36|World / Primary Cells by Cluster | 8.33e-06 | 195 | 63 | 5 | bc76a0586cc78f013cb96a2444e63e3c5daa3bc7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius|World / Primary Cells by Cluster | 8.33e-06 | 195 | 63 | 5 | 424d8e2bc7f7e68f74219de06dbbb671c8b4c24c | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.75e-06 | 197 | 63 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.75e-06 | 197 | 63 | 5 | 2abe27f6722fa0dab801bca4cd19e34c1fb4173e | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-gd_T|URO / Disease, condition lineage and cell class | 8.97e-06 | 198 | 63 | 5 | cb584f7754ef4e6d9ec7155022852f2d2676ab4f | |
| ToppCell | COVID-19_Severe-NK|COVID-19_Severe / disease group, cell group and cell class | 8.97e-06 | 198 | 63 | 5 | 0cb88084eac25604ec8f9b1497fb8d2433f1971c | |
| ToppCell | control-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.97e-06 | 198 | 63 | 5 | 13955a4026c97e11d94973ac87bf018f64a2616c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.19e-06 | 199 | 63 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 199 | 63 | 5 | 5059a1d4df7d9989c922007a8dcba98b1f5687d5 | |
| ToppCell | control-MAIT|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.41e-06 | 200 | 63 | 5 | aeea4bda2e38cc6db571ed2b47ce022d637619bd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.80e-05 | 123 | 63 | 4 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.17e-05 | 127 | 63 | 4 | 9bc55cb9f4bddb274930784d12a83b9dceb35cb7 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.47e-05 | 130 | 63 | 4 | 1491e8975520e99c527a5b5bee64875d124f7bf4 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-05 | 147 | 63 | 4 | 551c249f921ee0e70208abe207f2044d234d1ddc | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.23e-05 | 151 | 63 | 4 | 30225a1a7800b0ae19e16ac164f561379eedb99d | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.42e-05 | 158 | 63 | 4 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 160 | 63 | 4 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 160 | 63 | 4 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 7.98e-05 | 161 | 63 | 4 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 164 | 63 | 4 | 7a51365bad2910c130bd952805f7a1bef51be481 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.78e-05 | 165 | 63 | 4 | 5e7ee76f3dcddbd1b560bacd043f9001b0c18b5f | |
| ToppCell | CF-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 8.78e-05 | 165 | 63 | 4 | 69ad83f2e4da62acfdf0a5a299d8444932a61160 | |
| ToppCell | Severe-Lymphoid-NK-innate_T|Severe / Condition, Lineage, Cell class and cell subclass | 8.98e-05 | 166 | 63 | 4 | ee5ee75131fc0e22da0ceba3917f2104516af4b7 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.98e-05 | 166 | 63 | 4 | bb93db4613c067c56614ab1ca39e73ee46484387 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.98e-05 | 166 | 63 | 4 | c1f17a028bb27b8f202bcfffa7de7373b1cdd990 | |
| ToppCell | Severe-Lymphoid-NK-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 9.20e-05 | 167 | 63 | 4 | 8d41015871616ab7eced5104cd8f70d0efe504f2 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.20e-05 | 167 | 63 | 4 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 168 | 63 | 4 | 1df3c8c7a6dceb901805eaba7f86f9943f4f1a9d | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-05 | 168 | 63 | 4 | 6c758eb120faf06ff72d157b495e399191c79ec9 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 168 | 63 | 4 | 1586451d437b70b2dffe41d782b694702dcaf50b | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.63e-05 | 169 | 63 | 4 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-05 | 169 | 63 | 4 | 18ba8fc2ba8838484d3b223428cd41568e2ccb10 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.63e-05 | 169 | 63 | 4 | e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.63e-05 | 169 | 63 | 4 | d375a1df1ecc938f66bad92e54b8cda26ca9c472 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-05 | 169 | 63 | 4 | 47a63afd80cb7ba2258ba57d3084d8b2a7bc4e8d | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.63e-05 | 169 | 63 | 4 | 58f805c0be507bd5fadc9ea3555032daabbc8ab8 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 170 | 63 | 4 | 2b5b1f8d13b9806b76b44a53f47a23dd9ff09808 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 170 | 63 | 4 | 43c48267d8291c88263148a36fbb63c27f0e4f1c | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.85e-05 | 170 | 63 | 4 | 8e9b5f7bfb61f8d84d0b17fb0c191da4dabad63d | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 171 | 63 | 4 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 171 | 63 | 4 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-04 | 171 | 63 | 4 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | Control-MAIT|Control / Disease group and Cell class | 1.03e-04 | 172 | 63 | 4 | 552bc62e8e8bb0ac1cd0452f4410a3af087787eb | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 172 | 63 | 4 | 1b133be191252e7053faeacf9547730c3ae28d21 | |
| ToppCell | URO-Lymphocyte-T_NK-gdT|URO / Disease, Lineage and Cell Type | 1.03e-04 | 172 | 63 | 4 | 97b1eb95234639fcaa5ea3c4ba7ec2f4eb929dbf | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 172 | 63 | 4 | b3c53fd7e50f36de6a8585ae21d04e17932f262c | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 173 | 63 | 4 | e07e126e9dac6f1160cb3191d2e8374f39155d0d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 173 | 63 | 4 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 173 | 63 | 4 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 174 | 63 | 4 | 009e88a6c79689a5d88b0af50aa89aa03b33f800 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.10e-04 | 175 | 63 | 4 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-04 | 175 | 63 | 4 | 0ed053aa8353c72ff37fee830672704a3ddc7d85 | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 175 | 63 | 4 | bf1ef77d5fed2135ac83a4f7e445ab59d1538696 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-04 | 175 | 63 | 4 | 0124a3c4696b39cee8b566e94603d1d3d128bfa5 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.10e-04 | 175 | 63 | 4 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-04 | 175 | 63 | 4 | e219b61d6bc078d44ea7d06191d3462654d857a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-04 | 175 | 63 | 4 | bd16c80418bf71127e6f1e50edf83967c9218b42 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-04 | 175 | 63 | 4 | 0c6cf88818037bef67211c1a8fcb1e7d47711c1d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 1.13e-04 | 176 | 63 | 4 | 25c197d3b39deffa4801a1d12cdb54320cbae509 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 176 | 63 | 4 | 3027d34fd663c8a08544d469183dc45138916749 | |
| ToppCell | Control-Lymphoid-ILC_B|World / Disease state, Lineage and Cell class | 1.13e-04 | 176 | 63 | 4 | 57ad9c9f5fda6bc24695587ed14190514fd8d96a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.13e-04 | 176 | 63 | 4 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-NK_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 177 | 63 | 4 | be35bb178fbc149f8a12984c012d98b486325ba9 | |
| ToppCell | Control-Lymphoid-ILC_B|Control / Disease state, Lineage and Cell class | 1.15e-04 | 177 | 63 | 4 | 3d0f4b4054185ba77071efbe53df34fee84b9b24 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 177 | 63 | 4 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 178 | 63 | 4 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 178 | 63 | 4 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 178 | 63 | 4 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-04 | 179 | 63 | 4 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-04 | 179 | 63 | 4 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 180 | 63 | 4 | ca7c316027e31559103b2cab1a2c0de993e42e95 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 180 | 63 | 4 | eb26ba86fba26899e54c448afc25382ddc853013 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 180 | 63 | 4 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.23e-04 | 180 | 63 | 4 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-04 | 181 | 63 | 4 | c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 181 | 63 | 4 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.25e-04 | 181 | 63 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 181 | 63 | 4 | c1203787cc3f968147fabdd3c646a04be96f6552 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-04 | 181 | 63 | 4 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 181 | 63 | 4 | c2a8ee8679a1d71fcbff792cd516d3ce114f3ca6 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 181 | 63 | 4 | f7258af89f4cc89446ff6754bdaa769320af95d6 | |
| ToppCell | Healthy_donor-MAIT|Healthy_donor / disease group, cell group and cell class (v2) | 1.28e-04 | 182 | 63 | 4 | ac7c83464487ecde3df6804a99551307bd768f21 | |
| ToppCell | Adult-Immune-natural_killer_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.28e-04 | 182 | 63 | 4 | dbf47bf4754d8ec3bc3ab1d5be7a6c47a7afbf43 | |
| Computational | Genes in the cancer module 11. | 1.92e-04 | 540 | 42 | 9 | MODULE_11 | |
| Computational | Genes in the cancer module 100. | 2.03e-04 | 544 | 42 | 9 | MODULE_100 | |
| Computational | Genes in the cancer module 66. | 2.26e-04 | 552 | 42 | 9 | MODULE_66 | |
| Drug | sulfinpyrazone | 1.49e-07 | 87 | 63 | 6 | CID000005342 | |
| Drug | Iaci | 2.01e-07 | 5 | 63 | 3 | CID000656579 | |
| Drug | NSC 117356 | 3.85e-07 | 246 | 63 | 8 | CID000004112 | |
| Drug | PIHCA | 4.01e-07 | 6 | 63 | 3 | CID000108097 | |
| Drug | v 104 | 4.01e-07 | 6 | 63 | 3 | CID000107262 | |
| Drug | iodoarylazidoprazosin | 1.12e-06 | 8 | 63 | 3 | CID000115344 | |
| Drug | probenecid | 1.16e-06 | 123 | 63 | 6 | CID000004911 | |
| Drug | glutamate | EPRS1 SLC4A7 IMPDH1 SV2A GLS MTR PRKCZ HADHA FTCD MDH1 PSMD14 SLC1A7 ABCB1 | 1.85e-06 | 962 | 63 | 13 | CID000000611 |
| Drug | AC1NN9F1 | 2.39e-06 | 10 | 63 | 3 | CID000000410 | |
| Drug | mercaptoacetamide | 3.28e-06 | 11 | 63 | 3 | CID000012961 | |
| Drug | benzbromarone | 3.28e-06 | 37 | 63 | 4 | CID000002333 | |
| Drug | S 16020-2 | 5.66e-06 | 13 | 63 | 3 | CID000177329 | |
| Drug | niguldipine | 7.28e-06 | 45 | 63 | 4 | CID000001236 | |
| Drug | L3 23 | 7.54e-06 | 2 | 63 | 2 | CID000064984 | |
| Drug | naphthyl sulfate | 7.54e-06 | 2 | 63 | 2 | ctd:C029092 | |
| Drug | Burgess reagent | 7.54e-06 | 2 | 63 | 2 | CID002724994 | |
| Drug | 1-amino-4-chloroanthraquinone | 7.54e-06 | 2 | 63 | 2 | CID000017884 | |
| Drug | Protriptyline | 7.54e-06 | 2 | 63 | 2 | ctd:D011530 | |
| Drug | 1,9-dideoxyforskolin | 7.54e-06 | 2 | 63 | 2 | ctd:C047983 | |
| Drug | 4-methylumbelliferyl sulfate | 7.54e-06 | 2 | 63 | 2 | ctd:C019492 | |
| Drug | deoxyshikonin | 7.54e-06 | 2 | 63 | 2 | CID000098914 | |
| Drug | NSC3096 | 7.69e-06 | 98 | 63 | 5 | CID000002832 | |
| Drug | sodium | SLC6A2 SLC4A7 SLC18A2 GLS SLC6A20 SLC5A7 MTR CLDN4 PRKCZ MDH1 SLC1A7 SLC2A3 | 9.12e-06 | 944 | 63 | 12 | CID000000923 |
| Drug | 8-azido-ADP | 1.34e-05 | 17 | 63 | 3 | CID000121934 | |
| Drug | creatine | 1.56e-05 | 193 | 63 | 6 | CID000000586 | |
| Drug | AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A | 1.65e-05 | 195 | 63 | 6 | 6903_UP | |
| Drug | Enilconazole [35554-44-0]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.65e-05 | 195 | 63 | 6 | 5113_UP | |
| Drug | betaine | 1.91e-05 | 200 | 63 | 6 | CID000000247 | |
| Drug | Technetium Tc 99m Sestamibi | 2.26e-05 | 3 | 63 | 2 | ctd:D017256 | |
| Drug | Ribavirin | 2.26e-05 | 3 | 63 | 2 | DB00811 | |
| Drug | dendroamide A | 2.26e-05 | 3 | 63 | 2 | CID000177307 | |
| Drug | NK-250 | 2.26e-05 | 3 | 63 | 2 | CID000164220 | |
| Drug | D-Val-Thz | 2.26e-05 | 3 | 63 | 2 | CID003082826 | |
| Drug | Nortriptyline | 2.59e-05 | 21 | 63 | 3 | ctd:D009661 | |
| Drug | thioinosinic acid | 3.44e-05 | 23 | 63 | 3 | CID003034391 | |
| Drug | L-Glutamic Acid | 3.80e-05 | 68 | 63 | 4 | DB00142 | |
| Drug | cepharanthine | 4.26e-05 | 70 | 63 | 4 | CID000010206 | |
| Drug | 6-fluorometaraminol | 4.51e-05 | 4 | 63 | 2 | CID000159475 | |
| Drug | ethylphenidate | 4.51e-05 | 4 | 63 | 2 | CID003080846 | |
| Drug | dimethylaminobenzoate | 4.51e-05 | 4 | 63 | 2 | CID012241998 | |
| Drug | Fluorescent Dyes | 4.51e-05 | 4 | 63 | 2 | ctd:D005456 | |
| Drug | Ephedrine | 4.51e-05 | 4 | 63 | 2 | DB01364 | |
| Drug | 1-aminoanthraquinone | 4.51e-05 | 4 | 63 | 2 | CID000006710 | |
| Drug | 4-(4-Chlorophenyl)piperidine | 4.51e-05 | 4 | 63 | 2 | CID001203613 | |
| Drug | AC1NB35J | 4.51e-05 | 4 | 63 | 2 | CID003743673 | |
| Drug | 7,3',4'-trimethoxyflavone | 4.51e-05 | 4 | 63 | 2 | CID000154227 | |
| Drug | norsalsolinol | 4.51e-05 | 4 | 63 | 2 | CID000036937 | |
| Drug | sulfinosine | 4.51e-05 | 4 | 63 | 2 | CID000130209 | |
| Drug | erysolin | 4.51e-05 | 4 | 63 | 2 | CID003080557 | |
| Drug | tariquidar | 5.63e-05 | 27 | 63 | 3 | CID000148201 | |
| Drug | queuosine | 5.63e-05 | 27 | 63 | 3 | CID000042119 | |
| Drug | 4-epidoxorubicin | 5.66e-05 | 788 | 63 | 10 | CID000001690 | |
| Drug | hydroxyl radicals | USP14 IMPDH1 PTPRN2 SLC18A2 ENPP1 GLS MTR PRKCZ HADHA FTCD MDH1 ABCB1 ABCB4 | 6.40e-05 | 1341 | 63 | 13 | CID000000961 |
| Drug | hemicholinium-3 | 6.51e-05 | 78 | 63 | 4 | CID000003585 | |
| Drug | AC1L38YU | 6.84e-05 | 79 | 63 | 4 | CID000085196 | |
| Drug | NSC671054 | 7.50e-05 | 5 | 63 | 2 | CID005357223 | |
| Drug | lortalamine | 7.50e-05 | 5 | 63 | 2 | CID000051047 | |
| Drug | L-gamma-Glu-L-Leu | 7.50e-05 | 5 | 63 | 2 | CID000151023 | |
| Drug | succinonitrile | 7.50e-05 | 5 | 63 | 2 | CID000008062 | |
| Drug | Nomifensine | 7.50e-05 | 5 | 63 | 2 | ctd:D009627 | |
| Drug | AC1L2MCS | 7.50e-05 | 5 | 63 | 2 | CID000023441 | |
| Drug | Loratadine | 7.77e-05 | 30 | 63 | 3 | ctd:D017336 | |
| Drug | AC1LCF1F | 8.39e-05 | 161 | 63 | 5 | CID000627275 | |
| Drug | Tetracycline | 8.78e-05 | 668 | 63 | 9 | ctd:D013752 | |
| Drug | perfluoro-n-heptanoic acid | 1.04e-04 | 33 | 63 | 3 | ctd:C101815 | |
| Drug | AC1MJ1SO | 1.04e-04 | 33 | 63 | 3 | CID003084042 | |
| Drug | chloride | SLC6A2 SLC4A7 PTPRN2 SLC18A2 SLC6A20 SLC5A7 MTR CLDN4 MDH1 SLC1A7 ABCB1 | 1.08e-04 | 1029 | 63 | 11 | CID000000312 |
| Drug | Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.11e-04 | 171 | 63 | 5 | 3297_UP | |
| Drug | Dextroamphetamine | 1.12e-04 | 6 | 63 | 2 | DB01576 | |
| Drug | AC1L73U3 | 1.12e-04 | 6 | 63 | 2 | CID000354191 | |
| Drug | AC1L99H3 | 1.12e-04 | 6 | 63 | 2 | CID000440540 | |
| Drug | niaprazine | 1.12e-04 | 6 | 63 | 2 | CID000071919 | |
| Drug | laniquidar | 1.12e-04 | 6 | 63 | 2 | CID006450806 | |
| Drug | 1 sq | 1.12e-04 | 6 | 63 | 2 | CID000073742 | |
| Drug | alsterpaullone | 1.24e-04 | 35 | 63 | 3 | CID005005498 | |
| Drug | aristolochic acid I | 1.34e-04 | 178 | 63 | 5 | ctd:C000228 | |
| Drug | MCNU | 1.35e-04 | 36 | 63 | 3 | CID000071741 | |
| Drug | cimetidine | 1.38e-04 | 179 | 63 | 5 | CID000002756 | |
| Drug | pyridoxine | 1.40e-04 | 95 | 63 | 4 | CID000001054 | |
| Drug | pseudoisocyanin | 1.57e-04 | 7 | 63 | 2 | CID000075462 | |
| Drug | AC1LAQXR | 1.57e-04 | 7 | 63 | 2 | CID000473367 | |
| Drug | C12-NBD-PC | 1.57e-04 | 7 | 63 | 2 | CID006439314 | |
| Drug | 3,4-Methylenedioxymethamphetamine | 1.57e-04 | 7 | 63 | 2 | DB01454 | |
| Drug | MMDA | 1.57e-04 | 7 | 63 | 2 | DB01442 | |
| Drug | PEG-PPG-PEG | 1.57e-04 | 7 | 63 | 2 | CID010129990 | |
| Drug | sarcosinamide | 1.57e-04 | 7 | 63 | 2 | CID000151411 | |
| Drug | oracaine | 1.57e-04 | 7 | 63 | 2 | CID000004065 | |
| Drug | isovalerylshikonin | 1.57e-04 | 7 | 63 | 2 | CID000335426 | |
| Drug | CaLam | 1.72e-04 | 39 | 63 | 3 | CID004126474 | |
| Drug | vinblastine | 1.78e-04 | 189 | 63 | 5 | CID000013342 | |
| Drug | pyridoxal 5'-phosphate | 1.83e-04 | 301 | 63 | 6 | CID000001051 | |
| Drug | tetrabenazine | 1.85e-04 | 40 | 63 | 3 | CID000006018 | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.91e-04 | 192 | 63 | 5 | 2813_UP | |
| Drug | sulfobromophthalein | 1.92e-04 | 103 | 63 | 4 | CID000005345 | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; PC3; HT_HG-U133A | 2.01e-04 | 194 | 63 | 5 | 5051_DN | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 63 | 5 | 3938_UP | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.06e-04 | 195 | 63 | 5 | 5760_UP | |
| Drug | RTI-121 | 2.09e-04 | 8 | 63 | 2 | CID000122190 | |
| Drug | AC1L1GIZ | 2.09e-04 | 8 | 63 | 2 | CID000003703 | |
| Drug | 11-keto-beta-boswellic acid | 2.09e-04 | 8 | 63 | 2 | CID006918114 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.73e-05 | 157 | 60 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 2.43e-05 | 4 | 60 | 2 | 605462 | |
| Disease | Basal cell carcinoma, susceptibility to, 1 | 2.43e-05 | 4 | 60 | 2 | cv:C2751544 | |
| Disease | Oculo-dento-digital syndrome | 2.43e-05 | 4 | 60 | 2 | C0812437 | |
| Disease | toxic encephalopathy (biomarker_via_orthology) | 2.43e-05 | 4 | 60 | 2 | DOID:3602 (biomarker_via_orthology) | |
| Disease | Pigmented Basal Cell Carcinoma | 2.53e-05 | 28 | 60 | 3 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 2.81e-05 | 29 | 60 | 3 | C4721806 | |
| Disease | Basal Cell Nevus Syndrome | 4.05e-05 | 5 | 60 | 2 | C0004779 | |
| Disease | Schizophrenia | 6.95e-05 | 883 | 60 | 9 | C0036341 | |
| Disease | Colorectal Carcinoma | 8.48e-05 | 702 | 60 | 8 | C0009402 | |
| Disease | cholestasis (biomarker_via_orthology) | 1.38e-04 | 49 | 60 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Recurrent depression | 1.45e-04 | 9 | 60 | 2 | C0221480 | |
| Disease | gallbladder neoplasm | 1.45e-04 | 9 | 60 | 2 | EFO_0004606 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.45e-04 | 9 | 60 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Medulloblastoma | 1.46e-04 | 50 | 60 | 3 | C0025149 | |
| Disease | estrogen measurement | 1.81e-04 | 10 | 60 | 2 | EFO_0011007 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.20e-04 | 145 | 60 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | basal cell carcinoma (is_implicated_in) | 2.65e-04 | 12 | 60 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | Depressive disorder | 3.06e-04 | 289 | 60 | 5 | C0011581 | |
| Disease | Epstein-Barr virus infection | 3.34e-04 | 66 | 60 | 3 | EFO_0000769 | |
| Disease | Germ Cell Cancer | 4.20e-04 | 15 | 60 | 2 | C0740345 | |
| Disease | Germ cell tumor | 4.20e-04 | 15 | 60 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 4.20e-04 | 15 | 60 | 2 | C0205852 | |
| Disease | anemia (implicated_via_orthology) | 4.20e-04 | 15 | 60 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Embryonal Neoplasm | 4.20e-04 | 15 | 60 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 4.20e-04 | 15 | 60 | 2 | C0027658 | |
| Disease | Cancer, Embryonal | 4.20e-04 | 15 | 60 | 2 | C0751364 | |
| Disease | Cancer, Embryonal and Mixed | 4.20e-04 | 15 | 60 | 2 | C0751365 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 4.79e-04 | 16 | 60 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | Intrahepatic cholestasis of pregnancy | 4.79e-04 | 16 | 60 | 2 | EFO_0009048 | |
| Disease | Carcinoma of bladder | 6.09e-04 | 18 | 60 | 2 | C0699885 | |
| Disease | response to mepolizumab, Glucocorticoid use measurement | 6.09e-04 | 18 | 60 | 2 | EFO_0008459, EFO_0009942 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 7.55e-04 | 20 | 60 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | brain measurement, neuroimaging measurement | 8.71e-04 | 550 | 60 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | Immunologic Deficiency Syndromes | 1.00e-03 | 23 | 60 | 2 | C0021051 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 1.09e-03 | 24 | 60 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | indole-3-propionate measurement | 1.38e-03 | 27 | 60 | 2 | EFO_0010501 | |
| Disease | pancreatic cancer (is_implicated_in) | 1.56e-03 | 112 | 60 | 3 | DOID:1793 (is_implicated_in) | |
| Disease | Mental Depression | 1.79e-03 | 254 | 60 | 4 | C0011570 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.87e-03 | 257 | 60 | 4 | DOID:10652 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAGEIGFTMNMLDIG | 221 | O14977 | |
| LGYDLLMTMAGMSGG | 221 | Q13790 | |
| GMTGHLPDFCMLMVG | 266 | O00178 | |
| GLGVVMYEMMCGRLP | 331 | Q9Y243 | |
| GGILLVVPNVMGMMC | 486 | O94925 | |
| GLELDGMAELMAGLM | 326 | Q92932 | |
| HGAGLPLMMLVFGEM | 61 | P08183 | |
| GGSIHPMEMEMLSLF | 256 | Q9H2P9 | |
| GMESGVLMLMALDRY | 111 | Q8NGI2 | |
| GGVVQATGLVMMLMS | 371 | Q8NCK7 | |
| ATGLVMMLMSLGGLL | 376 | Q8NCK7 | |
| PGGDMMSLLIRMGIF | 786 | O95835 | |
| MLRGIGSGMKYLSDM | 726 | P54764 | |
| LDITPMMGVLDGVLM | 41 | P40925 | |
| VDGMVGMLMDGLKEL | 396 | P22413 | |
| GMESGVLMLMALDRY | 111 | Q8NGI0 | |
| ADMAIAMALMGGIGF | 76 | P20839 | |
| GGVCYLSMGMVVLLM | 56 | Q9NQX7 | |
| LSMGMVVLLMGLVFA | 61 | Q9NQX7 | |
| TIMAIAHGSGLPLMM | 61 | P21439 | |
| QELGAMGMGDLLSAM | 506 | P20393 | |
| RMGTKMMGGLGFHEV | 2526 | Q13315 | |
| IGIAVVMIFGMIFSM | 201 | P21926 | |
| VFFSATMGIMLGRMG | 226 | O00341 | |
| AAGMDFLGMKMVGEL | 186 | O15228 | |
| FLGMKMVGELLRMSG | 191 | O15228 | |
| GTMSILMGLDGMVLL | 176 | Q96JQ5 | |
| MVGVPAALDMMLTGR | 191 | P40939 | |
| MIGLGGMAFCSTLMT | 336 | P11169 | |
| IFFMVMPIMIGGFGN | 66 | P00395 | |
| VGRLGAMMGPLILMS | 471 | Q9NSA0 | |
| LVGMMNGGMSLVAFV | 171 | Q8IZD6 | |
| SVAKFLFMAGMMVGG | 146 | Q6T423 | |
| GKMLVETSMIGLMLG | 81 | Q9HBR0 | |
| MGAALGSMVGLMTYG | 366 | O95954 | |
| RAGVPMEVMGLMLGE | 46 | O00487 | |
| MGGLLFIPALMGEMF | 126 | Q9GZV3 | |
| MLLALGLDSSMGGME | 411 | P23975 | |
| GVMTMVHGDNMGLVL | 1281 | P07814 | |
| LMVGVMLGVCSVMGL | 956 | Q9Y6M7 | |
| TGLMIFILMGLSVFM | 1011 | Q9Y6M7 | |
| GMGLAAMSLIGVMFS | 141 | P53816 | |
| GMIVYLGMMAGAFIL | 151 | Q7L1I2 | |
| SVAKFVFMAGMMVGG | 146 | Q8IVM8 | |
| MVGPGFLSLGLMMLV | 91 | P0C851 | |
| MGLMVFLIYLGGMMV | 51 | P03923 | |
| LAMMTVELFGIMGFL | 996 | Q9Y6C5 | |
| LQKRIMVLDGGMGTM | 26 | Q99707 | |
| ALMTVELFGMMGLIG | 1061 | Q13635 | |
| NVMGMTGLVFAFMLG | 166 | G3V0H7 | |
| FFMLLMLGIGSMLGN | 396 | Q9NP91 | |
| MLGLIVYLGMMVGAF | 206 | Q7L0J3 | |
| MASMGLQVMGIALAV | 1 | O14493 | |
| MVLAVGVGVVGMVMG | 66 | Q8NHS1 | |
| MLLGMMARGKPEIVG | 776 | Q15021 | |
| MFSGLNLGLMALDPM | 271 | Q9H8M5 | |
| FVLGMGLMMVGVLIG | 191 | Q6YI46 | |
| MLVMEMAGGGPLHKF | 411 | P43403 | |
| LLMVAVMLGVCSIMG | 856 | Q6U841 | |
| AIGLGMLVLGVIMAM | 16 | Q9NW97 | |
| AMVGSAMMGGILLAL | 111 | O60830 | |
| SPFGMSLAMTGLMLG | 101 | Q9UK55 | |
| AMMERMGGFGSIIQL | 216 | Q9UJA5 | |
| GMTLLMMGSADALPE | 66 | P54578 | |
| VGFAIGMVDSSMMPI | 391 | Q05940 | |
| GTVGMCILIMQILGM | 206 | O75954 | |
| PLIIMGEVDGGMAML | 526 | Q8TEU8 | |
| ALGVLMFEMMAGRSP | 436 | Q05513 | |
| LEMMFTPTGVVMGAR | 496 | Q8WXR4 |